Emerging pathogens

References

• Beck-Sague CM, Jarwis WR. Secular trends in the epidemiol-ogy of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Surveillance System. J In-fect Dis 1993; 167: 1247–1251.
   Google Scholar
• Rees JR, Pinner RW, Hajjeh RA, Brandt ME Reingold AL. The epidemiological features of invasive mycotic infections in © 2000 ISHAM, Medical Mycology, 38, Suppl. I, 225-236 the San Francisco Bay Area, 1992-1993: Results of popula-tion-based laboratory active surveillance. Clin Infect Dis 1998; 27: 1138–1147.
   Google Scholar
• Hazen KC. New and emerging yeast pathogens. Clin Micro-biol Rev 1995; 8: 462–478.
   PubMed Web of Science ®Google Scholar
• Perfect JR, Schell WA. The new fungal opportunists are coming. Clin Infect Dis 1996; 22 (Suppl. 2): S112—S118.
   Google Scholar
• Ampel N. Emerging disease issues and fungal pathogens asso-ciated with HIV infection. Emerg Infect Dis 1996; 2: 109–116.
   PubMed Web of Science ®Google Scholar
• Fox JL. Fungal infection rates are increasing. Science 1993; 59: 515–518.
   Google Scholar
• Wheat J. Endemic mycoses in AIDS: a clinical review. Clin Microbiol Rev 1995; & 146–159.
   Google Scholar
• Wilson JD, Jones BM, Kinghorn GR. Bread-making as a source of vaginal infection with Saccharomyces cerevisiae: Report of a case in a woman and apparent transmission to her partner. Sex Transm Dis 1988; 15: 35–36.
   Google Scholar
• Tawfik OW, Papasian CJ, Dixon AY, Potter LM. Saccha-romyces cerevisiae pneumonia in a patient with acquired im-mune defiency syndrome. J Clin Microbiol 1989; 27: 1689–1691.
   PubMed Web of Science ®Google Scholar
• Sobel JD, Vazquez JA, Lynch M, Meriwether C, Zervos MJ. Vaginitis due to Saccharomyces cerevisiae: epidemiology, clini-cal aspects, and therapy. Clin Infect Dis 1993; 16: 93–99.
   Google Scholar
• Nyirjesy P, Vazquez JA, Ufberg DD, Sobel JD, Biokov DA, Buckley HR Saccharomyces cerevisiae vaginitis: transmission from yeast used in baking. Obstet Gynecol 1995; 86: 326–329.
   PubMed Web of Science ®Google Scholar
• Nielsen H, Stenderup J, Bruun B. Fungemia with Saccha-romycetaceae. Scand J Infect Dis 1990; 22: 581–584.
   PubMed Web of Science ®Google Scholar
• McCullough MJ, Clemons KV, Farina C, McCusker JH, Stevens DA. Epidemiological investigation of vaginal Saccha-romyces cerevisiae isolates by a genotypic method. J Clin Microbiol 1998; 36: 557–562.
   Google Scholar
• Cimolai N, Gill MJ, Church D. Saccharomyces cerevisiae fungemia: case report and review of the literature. Diag Mi-crobiol Infect Dis 1987; 8: 117.
   Google Scholar
• Aucott JN, Fayen J, Grossnicklas H, Morrissey A, Lederman MM, Salata RA. Invasive infection with Saccharomyces cere-visiae: report of three cases and review. Rev Infect Dis 1990; 12: 406–411.
   PubMedGoogle Scholar
• McCusker JH, Clemons KV, Stevens DA, Davis RW. Genetic characterization of pathogenic Saccharomyces cerevisiae iso-lates. Genetics 1994; 136: 1261–1269.
   PubMed Web of Science ®Google Scholar
• Clemons KV, McCusker JH, Davis RW, Stevens DA. Com-parative pathogenesis of clinical and nonclinical isolates of Saccharomyces cerevisiae. J Infect Dis 1994; 169: 859–867.
   PubMed Web of Science ®Google Scholar
• Byron JK, Clemons KV, McCusker JH, Davis RW, Stevens DA. Pathogenicity of Saccharomyces cerevisiae in complement factor five-deficient mice. Infect Immun 1995; 63: 478–485.
   Google Scholar
• Clemons KV, Park P, McCusker JH, McCullough MJ, Davis RW, Stevens DA. Application of DNA typing methods and genetic analysis to epidemiology and taxonomy of Saccha-romyces. J Clin Microbiol 1997; 35: 1822–1828.
   PubMed Web of Science ®Google Scholar
• McCusker JH, Clemons KV, Stevens DA, Davis RW. Saccha-romyces cerevisiae virulence phenotype as determined with CD-1 mice is associated with the ability to grow at 42 °C and form pseudohyphae. Infect Immun 1994; 62: 5447–5455.
   PubMed Web of Science ®Google Scholar
• McCullough MJ, Clemons KV, McCusker JH, Stevens DA. Species identification and virulence attributes of Saccha-romyces boulardii (nom. inval.). J Clin Microbiol 1998; 36: 2613–2617.
   PubMed Web of Science ®Google Scholar
• McCullough MJ, Clemons KV, McCusker JH, Stevens DA. Intergenic transcribed spacer PCR ribotyping for differentiation of Saccharomyces species and interspecific hybrids. J Gun Microbiol 1998; 36: 1035–1038.
   Web of Science ®Google Scholar
• Clemons KY, Hanson LC, Stevens DA. Colony phenotype switching in clinical and non-clinical isolates of Saccharomyces cerevisiae. J Med Vet Mycol 1996; 34: 259–264.
   Google Scholar
• Weger SD, Ganji A, Clemons KY, Byron JK, Stevens DA. Comparative virulence of petite and grand isolates of Saccha-romyces cerevisiae (Sc). 99th General Meeting of the American Society for Microbiology, Chicago, IL, May 30-June 3, 1999. Washington DC: American Society for Microbiology, 1999: Abstract F96.
   Google Scholar
• Ganji A, Weger SD, Clemons KY, Stevens DA. Correlation of petite formation frequency by isolates of Saccharomyces cere - visiae (SC) in vitro with virulence. 99th General Meeting of the American Society for Microbiology, Chicago, IL, May 30-June 3, 1999. Washington DC: American Society for Microbi-ology, 1999: Abstract F97.
   Google Scholar
• Zerva L, Hollis RJ, Pfaller MA. In vitro susceptibility testing and DNA typing of Saccharomyces cerevisiae clinical isolates. J Clin Microbiol 1996; 34: 3031–3034.
   Google Scholar
• Posteraro B, Sanguinetti M, D'Amore G, Masucci L, Morace G, Fadda G. Molecular and epidemiological characterization of vaginal Saccharomyces cerevisiae isolates. J Clin Microbiol 1999; 37: 2230–2235.
   Google Scholar
• Izadnia F, Wong CT, Kocoshis SA. Brewer's yeast and Sac-charomyces boulardii both attenuate Clostridium difficile-in-duced colonic secretion in the rat. Digest Dis Sci 1998; 43: 2055–2060.
   Google Scholar
• Pfaller M, Wenzel R Impact of the changing epidemiology of fungal infections in the 1990s. Ear J Clin Microbiol Infect Dis 1992; 11: 287–291.
   PubMed Web of Science ®Google Scholar
• Fischer-Hoch SP, Hutwagner L. Opportunistic candidiasis: an epidemic of the 1980s. Clin Infect Dis 1995; 21: 897–904.
   PubMed Web of Science ®Google Scholar
• Fridkin SK, Jarvis WR Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996; 9: 499–511.
   PubMed Web of Science ®Google Scholar
• Pfaller MA. Nosocomial candidiasis: emerging species, reser-voirs, and modes of transmission. Clin Infect Dis 1996; 22 (Suppl. 2): S89–S94.
   Google Scholar
• Coleman DC, Bennett DE, Sullivan DJ, et al. Oral Candida in HIV infection and AIDS: new perspectives/new approaches. Grit Rev Microbiol 1993; 19: 61–82.
   PubMed Web of Science ®Google Scholar
• Sullivan DJ, Henman MC, Moran GP, et al. Molecular ge-netic approaches to identification, epidemiology and taxon-omy of non-albicans Candida species. J Med Microbiol 1996; 44: 399–408.
   PubMed Web of Science ®Google Scholar
• Cooper CR. From bamboo rats to humans: the odyssey of Penicillium marneffei. ASM News 1998; 64: 390–397.
   Google Scholar
• Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Cole-man DC. Candida dubliniensis sp. nov.: phenotypic and molec-ular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiol 1995; 141: 1507–1521.
   Google Scholar
• Coleman DC, Sullivan DJ, Bennett DE, Moran GP, Barry HJ, Shanley DB. Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS 1997; 11: 557–567.
   PubMed Web of Science ®Google Scholar
• Coleman DC, Sullivan D, Harrington B, et al. Molecular and phenotypic analysis of Candida dubliniensis: a recently iden-tified species linked with oral candidosis in HIV-infected and AIDS patients. Oral Diseases 1997; 3 (Suppl. 1): S96–S101.
   Google Scholar
• Sullivan D, Haynes K, Bile J, et al. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals. J Clin Microbiol 1997; 35: 960–964.
   PubMed Web of Science ®Google Scholar
• Schmid J, Odds FC, Wiselka MJ, Nicholson KG, Soll DR. Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA finger-printing. J Clin Microbiol 1992; 30: 935–941.
   Google Scholar
• Sullivan D, Bennett B, Henman M, et al. Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human im-munodeficiency virus-positive and AIDS patients. J Clin Mi-crobiol 1993; 31: 2124–2133.
   Google Scholar
• Boerlin P, Boerlin-Petzold F, Durussel C, et al. Cluster of oral atypical Candida isolates in a group of human immunodefi-ciency virus-positive drug users. J Clin Microbiol 1995; 33: 1129–1135.
   PubMed Web of Science ®Google Scholar
• McCullough M, Ross B, Reade P. Characterization of geneti-cally distinct subgroup of Candida albicans strains isolated from oral cavities of patients infected with human im-munodeficiency virus. J Clin Microbiol 1995; 33: 696–700.
   Google Scholar
• Boucher H, Mercure S, Montplaisir S, Lemay G. A novel group I intron in Candida dubliniensis is homologous to a Candida albicans intron. Gene 1996; 180: 189–196.
   PubMed Web of Science ®Google Scholar
• Kurtzman CP, Robnett CJ. Identification of clinically impor-tant ascomycetous yeasts based on nucleotide divergence in the 5' end of the large-subunit (26S) ribosomal DNA gene. J Clin Microbiol 1997; 35: 1216–1223.
   PubMed Web of Science ®Google Scholar
• Gilfillan GD, Sullivan DJ, Haynes K, et al. Candida dublinien-sis: phylogeny and putative virulence factors. Microbiol 1998; 144: 829–838.
   PubMed Web of Science ®Google Scholar
• Donnelly SM, Sullivan DJ, Shanley DJ, Coleman DC. Phylo-genetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. Micro-biol 1999; 145: 1871-1882.
   Google Scholar
• Pincus DH, Coleman DC, Pruitt ER, et al. Rapid identifica-tion of Candida dubliniensis with commercial yeast identifica-tion systems. J Clin Microbiol 1999; 37: 3533–3539.
   PubMed Web of Science ®Google Scholar
• Gales AC, Pfaller MA, Houston AK, et al. Identification of Candida dubliniensis based on temperature and utilization of xylose and ce-methyl-D-glucoside as determined with the API 20C AUX and Vitek YBC systems. J Clin Microbiol 1999; 37: 3804–3808.
   PubMed Web of Science ®Google Scholar
• Schoofs A, Odds FC, Colebunders R, Leven M, Goosens H. Use of specialised isolation media for recognition and identifi-cation of Candida dubliniensis isolates from HIV-infected pa-tients. Eur J Clin Microbiol Infect Dis 1997; 16: 296–300.
   Google Scholar
• Bikandi J, San Milian R, Moragues MD, et al. Rapid identifi-cation of Candida dubliniensis by indirect immunofluorescence based on differential localization of antigens on C. dubliniensis blastospores and Candida albicans germ tubes. J Clin Micro-biol 1998; 36: 2428–2433.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick WR, Revanker SG, McAtee RK, et al. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. J Clin Microbiol 1998; 36: 3007–3012.
   PubMed Web of Science ®Google Scholar
• Odds FC, Van Nuffel L, Dams G. Prevalence of Candida dubliniensis isolates in a yeast stock collection. J Clin Micro-biol 1998; 36: 2869–2873.
   PubMed Web of Science ®Google Scholar
• Pinjon E, Sullivan D, Salkin I, Shanley D, Coleman D. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans. J Clin Microbiol 1998; 36: 2093–2095.
   Google Scholar
• Salkin IF, Pruitt WR, Padhye AA, et al. Distinctive carbohy-drate assimilation profiles used to identify the first clinical isolates of Candida dubliniensis recovered from the United States. J Clin Microbiol 1998; 36: 1467. 0 2000 ISHAM, Medical Mycology, 38, Suppl. I, 225–236
   Google Scholar
• Sullivan D, Coleman D. Candida dubliniensis: characteristics and identification. J Clin Microbiol 1998; 36: 329–334.
   PubMed Web of Science ®Google Scholar
• Jabra-Rizk MA, Baqui AA, Kelley JI, et al. Identification of Candida dubliniensis in a prospective study of patients in the United States. J Gun Microbiol 1999; 37: 321–326.
   Google Scholar
• Pfaller MA, Messer SA, Gee S, et al. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. J Clin Microbiol 1999; 37: 870–872.
   PubMed Web of Science ®Google Scholar
• Meis JFGM, RuhnkeM, De Pauw BE, etal. Candida dublinien-sis candidemia in patients with chemotherapy-induced neu-tropenia and bone marrow transplantation. Emerg Infect Dis 1999; 5: 150–153.
   PubMed Web of Science ®Google Scholar
• Brandt ME, Harrison LH, Pass M, et al. Candida dubliniensis fungemia: the first four cases in North America. Emerg Infect Dis 2000; 6: 46–49.
   PubMed Web of Science ®Google Scholar
• Polacheck I, Strahilevitz J, Sullivan D, et al. Recovery of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Israel. J Clin Microbiol 2000; 38: 170–174.
   PubMed Web of Science ®Google Scholar
• Willis AM, Coulter WA, Sullivan DJ, et al. Isolation of C. dubliniensis from insulin-using diabetes mellitus patients. J Oral Pathol Med 2000; 29: 86–90.
   Google Scholar
• Kamei K, McCullough MJ, Stevens DA. Initial case of Candida dubliniensis infection from Asia: non-mucosal infection. Med Mycol 2000; 38: 81–83.
   Google Scholar
• Tamura M, Watanabe K, Imai T, Mikami Y, Nishimura K. New PCR primer pairs specific for Candida dubliniensis and detection of the fungi from the Candida albicans clinical isolates in Japan. Clin Lab 2000; 46: 33–40.
   Google Scholar
• Sullivan DJ, Moran G, Donnelly S, et al. Candida dubliniensis: an update. Rev Iberoam Micol 1999; 16: 72–76.
   PubMedGoogle Scholar
• Borg-von Zepelin M, Niederhaus T, Tintelnot K. Adherence of clinical Candida dubliniensis isolates in the presence of flucona-zole. 14th Congress of the International Society for Human and Animal Mycology, Buenos Aires, Argentina, 8–12 May 2000. Buenos Aires: ISHAM, 2000: Abstract 38.
   Google Scholar
• Curfs JHAJ, Ruhnke M, Kullberg BJ, Verweij PE, Meis JFGM. Difference in virulence of Candida dubliniensis strains in mice and comparison to C. albicans. 14th Congress of the International Society for Human and Animal Mycology, Buenos Aires, Argentina, 8–12 May 2000. Buenos Aires: ISHAM, 2000: Abstract 528.
   Google Scholar
• Milan EP, Alves SH, Marthwr R, et al. First report of Candida dubliniensis in Brazilian AIDS patients. 14th Congress of the International Society for Human and Animal Mycology, Buenos Aires, Argentina, 8–12 May 2000. Buenos Aires: ISHAM, 2000: Abstract 153.
   Google Scholar
• Moran GP, Sullivan DJ, Henman MC, et al. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant deriva-tives in vitro. Antimicrob Agents Chemother 1997; 41: 617–623.
   PubMed Web of Science ®Google Scholar
• Joly S, Pujol C, Rysz M, Vargas K, Soll DR. Development and characterization of complex DNA fingerprinting probes for the infectious yeast Candida dubliniensis. J Clin Microbiol 1999; 37: 1035–1044.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Refer-ence method for broth dilution antifungal susceptibility testing of yeast. Approved standard M27A Wayne, PA National Committee of Clinical Laboratory Standards, 1997.
   Google Scholar
• Moran GP, Sanglard D, Donnelly SM, et al. Identification and expression of multidrug transporters responsible for flucona-zole resistance in Candida dubliniensis. Antimicrob Agents Chemother 1998; 42: 1819–1830.
   PubMed Web of Science ®Google Scholar
• Albertson GD, Niimi M, Cannon RD, Jenkinson HF. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob Agents Chemother 1996; 40: 2835–2841.
   PubMed Web of Science ®Google Scholar
• Sanglard D, Kuchler K, Ischer F, et al. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 1995; 39: 2378–2386.
   PubMed Web of Science ®Google Scholar
• Cho CT, Vats TS, Lowman JT, Bransberg JVV, Tosh FE. Fusarium solani infection during treatment for acute leukemia. J Pediat 1973; 83: 1028–1031.
   Google Scholar
• Anaissie E, Kantarjian H, Jones P, et al. Fusarium, a newly recognized fungal pathogen in immunosuppressed patients. Cancer 1986; 57: 2141.
   PubMed Web of Science ®Google Scholar
• Martino P, Gastaldi R, Raccah R, Girmenia C. Clinical patterns of Fusarium infections in immunocompromiseid pa-tients. J Infect 1994; 28: 7–15.
   PubMedGoogle Scholar
• Rabodonirina M, Piens MA, Monier MF, et al. Fusarium infections in immunocompromiseid patients: Case reports and literature review. Eur J Clin Microbiol Infect Dis 1994; 13: 152–161.
   PubMed Web of Science ®Google Scholar
• Guano J, Gene J. Opportunistic fusaiial infections in humans. Eur J Clin Microbiol Infect Dis 1995; 14: 741–754.
   PubMed Web of Science ®Google Scholar
• Lavarde V, Hennequin C. Infections a Fusarium. Encyclopedie Medico-Chirurgicale, Maladies Infectieuses. Paris: Elsevier, 1998; 1–6.
   Google Scholar
• Krcmery VJ, Kunova E, Jesenska Z, et al. Invasive mold infections in cancer patients: 5 years experience with Asper-gillus, Mucor, Fusarium and Acremonium infections. Sup Care Cancer 1996; 4: 39–45.
   PubMed Web of Science ®Google Scholar
• Boutati El, Anaissie El. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years experience at a cancer center and implication for management. Blood 1997; 90: 999–1008.
   PubMed Web of Science ®Google Scholar
• Hennequin C, Lavarde V, Poirot JL, et al (French 'Groupe d'Etudes des Mycoses Opportunistes' GEMO). Invasive Fusar-ium infections: a retrospective survey of 31 cases. J Med Vet Mycol 1997; 35: 107–114.
   Google Scholar
• Amey KL, Tiernan R, Judson MA. Primary pulmonary in-volvement of Fusarium solani in a lung transplant recipient. Chest 1997; 112: 1128–1130.
   Google Scholar
• Legrand C, Anaissie E, Hashem R, et al. Experimental fusarial hyalohyphomycosis in a murine model. J Infect Dis 1991; 164: 944–948.
   PubMed Web of Science ®Google Scholar
• Booth C. The Genus Fusarium. Kew: Commonwealth Mycol-ogy Institute, 1971.
   Google Scholar
• Thomas P, Geraldine P. Fungal keratitis due to Fusarium and other fungi. J Mycol Med 1992; 2: 121–131.
   Google Scholar
• Cuero RG. Ecological distribution of Fusarium solani and its opportunistic action related to mycotic keratitis in Cali, Colom-bia. J Clin Microbiol 1980; 12: 455–461.
   PubMed Web of Science ®Google Scholar
• De Bièvre C. Les champignons du milieu extérieur responsables d'allergies. Bull Soc Fr Mycol Med 1982; 2: 363–372.
   Google Scholar
• Derouin F, Ribaud P, Bouakline A, et al. Evaluation of an environmental control strategy for prevention of nosocomial invasive aspergillosis. 38th Interscience Conference on Antimi-crobial Agents and Chemotherapy, San Diego, CA, 24–27 September 1998. Washington DC: American Society for Micro-biology, 1998: Abstract K92.
   Google Scholar
• Warns A, Gaustad P, Meis J, Verweij P, Abrahamsen T. Water as a source of filamentous fungi in a childhood bone marrow transplantation unit. 39th Interscience Conference on Antimicro-bial Agents and Chemotherapy, San Francisco, CA, 26–290 2000 ISHAM, Medical Mycology, 38, Suppl. I, 225–236 aSeptember 1999. Washington DC: American Society for Micro-biology, 1999: Abstract J1909.
   Google Scholar
• Pinel C, Parat S, Grillot R, Perdrix A. Mycotoxines. Encyclo-pédie Médico-Chirurgicale, Toxicologie Pathologie Profes - sionelle. Paris: Elsevier, 1998: 1–5.
   Google Scholar
• Ciacci-Zanella JR, Jones C. Fumosinin BI, a mycotoxin con-taminant of cereal grains and inducer of apoptosis via the tumour necrosis factor pathway and caspase activation. Food Chem Toxicol 1999; 37: 703–712.
   Google Scholar
• Wu M, Cook M, Chu FS, etal. Case study of bovine dermatitis caused by oat straw infected with Fusarium sporotrichoides. Vet Res 1997; 140: 399–400.
   Google Scholar
• Snidjers CH, Samson RA, Hoekstra ES, et al. Analysis of Fusarium causing dermal toxicosis in marran grass planters. Mycopathologia 1996; 135: 119–280.
   PubMed Web of Science ®Google Scholar
• Sutton P, Newcombe NR, Waring P, Mullbacher A. In vivo suppressive activity of gliotoxin, a metabolite produced by human pathogenic fungi. Infect Immun 1994; 62: 1192–1198.
   PubMed Web of Science ®Google Scholar
• Kiryu H, Yoshida S, Suenaga Y, Asahi M. Invasion and survival of Fusarium solani in the dexamethasone-treated cornea of rabbits. J Med Vet Mycol 1991; 29: 395–406.
   PubMedGoogle Scholar
• Kiehn TB, Nelson PE, Bernard EM, et al. Catheter-associated fungemia caused by Fusarium chlamydosporumin a patient with lymphocytic lymphoma. J Clin Microbiol 1985; 21: 501–504.
   PubMed Web of Science ®Google Scholar
• Guano J, Pujol J, Mayayo E. In vitro and in vivo experimental activities of antifungal agents against Fusarium solani. Antimi-crob Agents Chemother 1999; 43: 1256–1257.
   Google Scholar
• Pujol I, Guarro J, Sala J, Riba MD. Effects of incubation temperature, inoculum size, and time of reading on broth microdilution susceptibility test results for Amphotericin B against Fusarium. Antimicrob Agents Chemother 1997; 41: 808–811.
   PubMed Web of Science ®Google Scholar
• Alikan S, Lozano-Chiu M, Paetmick V, Nangia S, Rex JH. Microdilution susceptibility testing of amphotericinB, itracona-zole, and voriconazole against clinical isolates of Aspergillus and Fusarium species. J Clin Microbiol 1999; 37: 3946–3951.
   PubMed Web of Science ®Google Scholar
• Sekhon AS, Padhye AA, Garg AK, Ahmad H, Moledina N. In vitro sensitivity of medically significant Fusarium species to various antimycotics. Chemotherapy 1994; 40: 239–244.
   Google Scholar
• Barnes RA, Prentice AG, Rogers TRF, et al. (Working party of the British Society for Antimicrobial Chemotherapy). Ther-apy of deep fungal infection in haematological malignancy. J Antimicrob Chemother 1997; 40: 779–788.
   PubMed Web of Science ®Google Scholar
• Denning DW, Evans EGV, Kibbler CC, et al. Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. Eur J Clin Micro-biol Infect Dis 1997; 16: 424–436.
   PubMed Web of Science ®Google Scholar
• Grillot R. Mycoses profondes de l'immunodéprime et du patient débilité. In: Grillot R, ed. Les Mycoses Humaines: Démarche Diagnostique. Paris: Elsevier, 1996: 175–200.
   Google Scholar
• Yoshida M, Obayashi T, Iwama A, et al. Detection of plasma (1-3)-I3-D-glucan in patients with Fusarium, Trichosporon, Sac-charomyces and Acremonium fungaemias. J Med Vet Mycol 1997; 35: 371–374.
   PubMedGoogle Scholar
• Jensen HE, SchonheyderHC, Hotchi M, Kaufman L. Diagnosis of systemic mycoses by specific immunohistochemical tests. APMIS 1996; 104: 241–258.
   PubMed Web of Science ®Google Scholar
• Liu K, Howell D, Perfect JR, Schell WA. Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces, and Acremonium species by histopathology. Am J Gun Pathol 1998; 109: 45–54.
   PubMed Web of Science ®Google Scholar
• Kaufman L, Standard PG, Jalbert M, Kraft DE. Immunohis-tologic identification of Aspergillus spp. and other hyaline fungi by using polyclonal fluorescent antibodies. J Gun Microbiol 1997; 35: 2206–2209.
   Google Scholar
• Hue FX, Huerre M, Rouffault MA, De Bievre C. Specific detection of Fusarium species in blood and tissues by a PCR technique. J Gun Microbiol 1999; 37: 2434–2438.
   Google Scholar
• Campbell CK, Johnson EM, Philpot CM, Warnock DW. Moulds with enteroblastic conidia adhering in wet masses. In: Campbell CK, Johnson EM, Philpot CM, Warnock DW, eds. Identification of Pathogenic Fungi. London: Public Health Laboratory Service, 1996: 146–185.
   Google Scholar
• Guano J, Gene J. Fusarium infections. Criteria for the identifi-cation of the responsible species. Mycoses 1992; 35: 109–114.
   Google Scholar
• Koenig H. Guide de Mycologie Médicale. Piotiers: Ellipses, 1995.
   Google Scholar
• Issakainen J, Jalava J, Saari J, Campbell CK. Relationships of Scedosporium prolificans with Petriella confirmed by partial LSU rDNA sequences. Mycol Res 1999; 103: 1179–1184.
   Web of Science ®Google Scholar
• Issakainen J, Jalava J, Eerola E, Campbell CK. Relatedness of Pseudallescheria, Scedosporium and Graphium pro parte based on SSU rDNA sequences. J Med Vet Mycol 1997; 35:389–398.
   PubMedGoogle Scholar
• de Hoog GS, Guarro J (eds). Atlas of Clinical Fungi. Baam: Centraalbureau voor Schimmelcultures, 1995.
   Google Scholar
• Gosbell IB, Morris ML, Gallo JH, etal. Clinical pathologic and epidemiologic features of infection with Scedosporium prolifi-cans: four cases and review. Clin Microbiol Infect 1999; 5: 672–686.
   Google Scholar
• Berenguer J, Rodriguez-Tudela JL, Richard C, et al. Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of literature. Medicine 1997; 76: 256–265.
   Google Scholar
• Guano J, Gams W, Pujol I, Gene J. Acremonium species: new emerging fungal opportunists - in vitro antifungal susceptibil-ities and review. Clin Infect Dis 1997; 25: 1222–1229.
   PubMed Web of Science ®Google Scholar
• Wood GM, McCormack JG, Muir DB, et al. Clinical features of human infection with Scedosporium imflatum. Clin Infect Dis 1992; 14: 1027–1033.
   PubMed Web of Science ®Google Scholar
• Garcia-Ruiz JC, Amutio E, Hernández I, et al. Clinical resolu-tion of Scedosporium prolificans pneumonia associated with treatment with liposomal amphotericin B in a patient with acute leukemia. Rev Iberoam Micol 1998; 15: 158–159.
   Google Scholar
• Bouza E, Muhoz P, Vega L, et al. Clinical resolution of Scedosporium prolificans fungemia associated with reversal of neutropenic following administration of granulocyte colony-stimulating factor. Clin Infect Dis 1996; 23: 192–193.
   PubMed Web of Science ®Google Scholar
• Hennebert GL, Desai BG. Lomentospora prolificans, a new hyphomycete from greenhouse soil. M ycot axon 1974; 1: 45–50.
   Google Scholar
• Summerbell RC, Krajden S, Kane J. Potted plants in hospitals as reservoirs of pathogenic fungi. Mycopathologia 1989; 106: 13–22.
   Google Scholar
• Muhoz P, Peldez T, Marfin-Rabadan P, Rodriguw-Creixéms M, Mensalvas A, Bouza E. Increment() de las infecciones por Scedosporium prolificans en un hospital general. VIII Congreso de la Sociedad Espanola de Enfermedades Infecciosas y Microbi-ologia Clinica, Palma de Mallorca, 24–27 May 1998. Madrid: SEIMC, 1998: Abstract 34–12.
   Google Scholar
• Duran MT, Larriba L, Rosales M, Torres JP, Molina M, Guerrero A. Transmisión aérea de Scedosporium prolificans en la infección nosocomial. VIII Congreso de la Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica, Palma de Mallorca, 24–27 May 1998. Madrid: SEIMC, 1998: Abstract 34–13.
   Google Scholar
• Cano J, Guano J, Mayayo E, Fernandez-Ballart J. Experimen-tal infection with Scedosporiuminflatum. J Med Vet Myco11992; 30: 413–420.
   PubMedGoogle Scholar